ACMA Introduces First Ever Accredited, Professional Certification for Specialty Pharmaceutical Sales Professionals
ACMA Introduces First Ever Accredited, Professional Certification for Specialty Pharmaceutical Sales Professionals
NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA), a globally recognized leader and the first and only accrediting body for the pharmaceutical industry, today announced the launch of the first accredited, professional certification program for Specialty Pharmaceutical Sales Professionals. The Certified Specialty Pharmaceutical Professional or (CSPP) Program, is the first and only accredited certification for the rapidly growing area of specialty pharmaceutical sales.
紐約， 2023年11月14日 /PRNewswire/ — 醫學事務認證委員會（ACMA）是全球公認的領導者，也是製藥行業第一個也是唯一的認證機構，今天宣佈啓動首個針對特種藥品銷售專業人員的認證計劃。認證特種製藥專業人員或（CSPP）計劃是快速增長的特種藥品銷售領域的第一個也是唯一的認可認證。
As of October 2023, there are approximately 5000 specialty drugs in the Food and Drug Administration (FDA) pipeline for review. According to a report by the Academy of Managed Care Pharmacy (AMCP), there are approximately 31 specialty drugs in late-stage development that were or were likely to be approved by the FDA in 2023. Specialty pharmaceutical sales cover a variety of conditions including cancer, inflammatory diseases, and neurological disorders.
截至 2023 年 10 月，美國食品藥品監督管理局（FDA）有大約5000種特種藥物有待審查。根據管理醫療藥房學會（AMCP）的一份報告，大約有31種處於後期開發階段的特種藥物已經或可能在2023年獲得FDA的批准。特種藥品的銷售涵蓋各種疾病，包括癌症、炎症性疾病和神經系統疾病。
"The increased focus by pharmaceutical manufacturers on specialty products means that there will be a greater need for specialized expertise in the area of specialty pharmaceuticals" said William Soliman, Ph.D., BCMAS, ACMA Founder and CEO. "The CSPP program is the most comprehensive training and certification program built for specialty pharmaceutical sales professionals covering both clinical and scientific areas as well as aspects related to biosimilars, drug development, value based care, biologics, and pharmaceutical compliance and regulatory affairs."
“製藥商越來越關注特種產品，這意味着對特種藥品領域專業知識的需求將增加。” ACMA創始人兼首席執行官BCMAS博士威廉·索利曼說。“CSPP 計劃是專爲專業藥品銷售專業人員設計的最全面的培訓和認證計劃，涵蓋臨床和科學領域以及與生物仿製藥、藥物開發、基於價值的護理、生物製劑以及藥品合規和監管事務相關的方面。”
CSPP is self-paced and online making it easy for full-time professionals to get certified and accredited. The program takes about 20 hours to complete and includes 24/7 online support for learners via live chat.
CSPP 是自定進度的、在線的，使全職專業人員可以輕鬆獲得認證和認證。該計劃大約需要20個小時才能完成，包括通過實時聊天爲學員提供全天候在線支持。
The ACMA is committed to promoting best practices and ensuring the highest-level of professionalism and integrity in the pharmaceutical industry. The CSPP certification program signifies ACMA's commitment to equipping specialty pharmaceutical sales professionals with the tools and knowledge they need to thrive in the rapidly growing specialty pharmaceuticals field.
ACMA致力於推廣最佳實踐，確保製藥行業最高水平的專業水平和誠信水平。CSPP 認證計劃表明 ACMA 致力於爲專業藥品銷售專業人員提供在快速增長的特種製藥領域蓬勃發展所需的工具和知識。
About the Accreditation Council for Medical Affairs (ACMA)
關於醫學事務認證委員會 (ACMA)
The ACMA is a globally recognized, award-winning organization providing solutions for certification, training, analytics, and insights to support the healthcare and life sciences industries. From Medical Affairs to Market Access, Managed Care, Biologics/Biosimilars, Pharmaceutical Sales and Market Research, the ACMA is the standard in the industry for certifying and credentialing pharmaceutical industry professionals in over 80+ countries. The ACMA works with Industry, Regulators, and Academia, among others, to further its mission: Establishing Best-in-Class Practices across the Life Sciences Industry to ensure the most rigorous quality/competency standards are established and globally enforced to elevate patient care. To learn more about CSPP, visit
ACMA 是一家全球認可、屢獲殊榮的組織，提供認證、培訓、分析和見解解決方案，爲醫療保健和生命科學行業提供支持。從醫療事務到市場準入、管理式護理、生物製劑/生物仿製藥、藥品銷售和市場研究，ACMA是對80多個國家的製藥行業專業人員進行認證和認證的行業標準。ACMA 與業界、監管機構和學術界等合作，以進一步實現其使命：在整個生命科學行業建立一流的實踐，確保建立最嚴格的質量/能力標準並在全球範圍內得到執行，以提升患者護理水平。要了解有關 CSPP 的更多信息，請訪問
Contact
Vivian Rivera
Email: [email protected]
Tel: 1-646-619-3566
聯繫我們
薇薇安·里維拉
電子郵件： [電子郵件保護]
電話：1-646-619-3566
SOURCE Accreditation Council for Medical Affairs
來源：醫學事務認證委員會
譯文內容由第三人軟體翻譯。